Product

Reviderm 0.01%

  • Description
  • HOW TO USE
  • WARNING AND CAUTION

Product Description

Active Ingridients and Indication

ReviDerm® 0,01 contains 0.01% Tretinoin in a cream base substance.
1. Help to relieve fine Wrinkles on face skin.
2. 0,01 and 0,02 ReviDerm are advised for patient who just starts tretinoin therapy, or to maintain the achieved treatment results after high content tretinoin administration for photodamage treatment.

Contraindication

Stop using this product, in case of irritation and excessive sensitiveness

Storage
Store below 300 C
Packaging
Box, Aluminium tube of 10g and 15g
ON MEDICAL PRESCRIPTION ONLY

KEEP OUT OF REACH OF CHILDREN 

 P.T SURYA DERMATO MEDICAL LABORATORIES Surabaya, Indonesia
 No. Reg :DKL 0528604129A1
  1. Before applying tretinoin, wash patient face first with mild soap, then dry it off, and wait for 20 - 30 minutes before applying Revi Derm.
  2. Apply gently and in a thin layer, once a day before sleep (at night) on the affected skin (where fine wrinkles occur).
  3. Skin rejuvenation requires long term treatment. Marked with skin smoothness, the treatment result is achieved within +12 weeks. After 24 weeks, it will appear wrinkle line improvement, and treatment may be continued to achieve perfection. Discontinuation trebinoin usage will reduce the improvement effect. Unknown efficacy and security tretinoin of more than 52 week usage.
  4. Following the achievement of the treatment result, it is necessary to maintain the progress achieved by reducing the treatment period frequency
  1. Do not apply this product adjacent to eyes, mouth, nose corner, and other mucous membranes.
  2. Stop tretinoin usage in case of sensitivity, such as chemical irritation, or systemic side effects.
  3. Carefully use this product to eczema patient, since trebinoin may cause severe irritation to the patient.
  4. Avoid sunray contact during its application, and apply moisturized sunscreen at noon.
  5. Patient with Sunburn skin should be firstly recovered before using this product.
  6. Pregnant mother : no accurate study on pregnant mother. Therefore tretinoin should not be used during pregnancy period.
  7. Lactating mother: unknown case, whether tretinoin is excreted to Breast Milk. As mostly products are excreted through breast milik, uretinoin usage should be postponed first until the end of lactating period.
  8. Children : Unknown efficacy and security on patient under 18 years old
Categories: ,